Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-β peptides, systemic ammonia and erythrocyte energy metabolism.

Kosenko EA, Solomadin IN, Tikhonova LA, Reddy VP, Aliev G, Kaminsky YG.

CNS Neurol Disord Drug Targets. 2014 Feb;13(1):112-9. Review.

PMID:
24040810
2.

[Oxidative stress and Alzheimer's disease].

Liu XJ, Yang W, Qi JS.

Sheng Li Xue Bao. 2012 Feb 25;64(1):87-95. Review. Chinese.

3.

Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.

Tayler H, Fraser T, Miners JS, Kehoe PG, Love S.

J Alzheimers Dis. 2010;22(4):1363-73. doi: 10.3233/JAD-2010-101368.

PMID:
20930272
4.

Amyloid-β production: major link between oxidative stress and BACE1.

Tamagno E, Guglielmotto M, Monteleone D, Tabaton M.

Neurotox Res. 2012 Oct;22(3):208-19. doi: 10.1007/s12640-011-9283-6. Epub 2011 Oct 15. Review.

PMID:
22002808
5.

Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.

Takeda S, Sato N, Rakugi H, Morishita R.

Mol Biosyst. 2011 Jun;7(6):1822-7. doi: 10.1039/c0mb00302f. Epub 2011 Mar 24. Review.

PMID:
21431241
6.

β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.

Wan L, Nie G, Zhang J, Luo Y, Zhang P, Zhang Z, Zhao B.

Free Radic Biol Med. 2011 Jan 1;50(1):122-9. doi: 10.1016/j.freeradbiomed.2010.10.707. Epub 2010 Oct 26.

PMID:
21034809
7.

Metals and amyloid-beta in Alzheimer's disease.

Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX.

Int J Exp Pathol. 2005 Jun;86(3):147-59. Review.

8.

A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.

Heininger K.

Rev Neurosci. 2000;11 Spec No:213-328. Review.

PMID:
11065271
9.

Untangling amyloid-β, tau, and metals in Alzheimer's disease.

Savelieff MG, Lee S, Liu Y, Lim MH.

ACS Chem Biol. 2013 May 17;8(5):856-65. doi: 10.1021/cb400080f. Epub 2013 Mar 18. Review.

PMID:
23506614
10.

Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Sultana R, Perluigi M, Butterfield DA.

Acta Neuropathol. 2009 Jul;118(1):131-50. doi: 10.1007/s00401-009-0517-0. Epub 2009 Mar 14. Review.

11.

Iron: a pathological mediator of Alzheimer disease?

Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, Smith MA.

Dev Neurosci. 2002;24(2-3):184-7. Review.

PMID:
12401957
12.

2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.

Yao J, Chen S, Mao Z, Cadenas E, Brinton RD.

PLoS One. 2011;6(7):e21788. doi: 10.1371/journal.pone.0021788. Epub 2011 Jul 1.

14.

Oxidative stress and β-amyloid protein in Alzheimer's disease.

Cai Z, Zhao B, Ratka A.

Neuromolecular Med. 2011 Dec;13(4):223-50. doi: 10.1007/s12017-011-8155-9. Epub 2011 Sep 8. Review.

PMID:
21901428
15.

Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability.

Allaman I, Gavillet M, Bélanger M, Laroche T, Viertl D, Lashuel HA, Magistretti PJ.

J Neurosci. 2010 Mar 3;30(9):3326-38. doi: 10.1523/JNEUROSCI.5098-09.2010.

16.

Epigenetics, oxidative stress, and Alzheimer disease.

Zawia NH, Lahiri DK, Cardozo-Pelaez F.

Free Radic Biol Med. 2009 May 1;46(9):1241-9. doi: 10.1016/j.freeradbiomed.2009.02.006. Epub 2009 Feb 23. Review.

17.

Ammonia and Alzheimer's disease.

Seiler N.

Neurochem Int. 2002 Aug-Sep;41(2-3):189-207. Review.

PMID:
12020619
18.

Oxidative stress signaling in Alzheimer's disease.

Su B, Wang X, Nunomura A, Moreira PI, Lee HG, Perry G, Smith MA, Zhu X.

Curr Alzheimer Res. 2008 Dec;5(6):525-32. Review.

19.

Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.

Calabrese V, Scapagnini G, Colombrita C, Ravagna A, Pennisi G, Giuffrida Stella AM, Galli F, Butterfield DA.

Amino Acids. 2003 Dec;25(3-4):437-44. Epub 2003 Nov 7. Review.

PMID:
14661103
20.

Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.

Liu G, Men P, Kudo W, Perry G, Smith MA.

Neurosci Lett. 2009 May 22;455(3):187-90. doi: 10.1016/j.neulet.2009.03.064. Epub 2009 Mar 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk